Abstract
Leung and colleagues established a biobank of patient-derived gastric cancer organoids that encompasses a diverse array of subtypes and maintained long-term similarity to the original tumors. They used the organoids to perform large-scale drug screening that identified potential target drugs and could guide patient drug selection.
| Original language | English |
|---|---|
| Pages (from-to) | 882-897.e11 |
| Journal | Cell stem cell |
| Volume | 23 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 6 Dec 2018 |
Keywords
- ARHGAP fusions
- EBV genome
- RHOA mutations
- biobank
- drug screening
- gastric cancer
- heterogeneity
- organoid culture
- transcriptome sequencing
- whole-exome sequencing
Fingerprint
Dive into the research topics of 'A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver